生物活性

• 描述Anisodamine is an inhibitor of alpha-1 adrenergic receptors and mAChRs isolated from Chinese solanacea plant.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT01929044	Intestinal Diseases	Phase 3	Completed	-	China ... more >> 202.848.86016 Boehringer Ingelheim Investigational Site Baotou, China 202.848.86008 Boehringer Ingelheim Investigational Site Beijing, China 202.848.86009 Boehringer Ingelheim Investigational Site Beijing, China 202.848.86010 Boehringer Ingelheim Investigational Site Beijing, China 202.848.86013 Boehringer Ingelheim Investigational Site Beijing, China 202.848.86012 Boehringer Ingelheim Investigational Site Changchun, China 202.848.86020 Boehringer Ingelheim Investigational Site Changsha, China 202.848.86018 Boehringer Ingelheim Investigational Site Chenzhou, China 202.848.86007 Boehringer Ingelheim Investigational Site Chongqing, China 202.848.86021 Boehringer Ingelheim Investigational Site Chongqing, China 202.848.86006 Boehringer Ingelheim Investigational Site Guangzhou, China 202.848.86003 Boehringer Ingelheim Investigational Site Hangzhou, China 202.848.86022 Boehringer Ingelheim Investigational Site Huanggang, China 202.848.86001 Boehringer Ingelheim Investigational Site Shanghai, China 202.848.86011 Boehringer Ingelheim Investigational Site Shanghai, China 202.848.86015 Boehringer Ingelheim Investigational Site Shenyang, China 202.848.86014 Boehringer Ingelheim Investigational Site Shijiazhuang, China 202.848.86019 Boehringer Ingelheim Investigational Site Wenzhou, China 202.848.86004 Boehringer Ingelheim Investigational Site Wuhan, China 202.848.86005 Boehringer Ingelheim Investigational Site Wuhan, China Collapse <<
  NCT01929044	-	-	Completed	-	-
  NCT02442440	Septic Shock	Phase 1 Phase 2	Unknown	-	China, Guangdong ... more >> Huizhou first hospital Not yet recruiting Huizhou, Guangdong, China, 516000 Contact: Xiaopeng Feng, MD       fengxiaopeng1977@163.com    China, Hubei Union Hospital, Tongji medical collegue, Huazhong university of Science and Technology Recruiting Wuhan, Hubei, China Contact: You Shang, MD       shang_you@126.com    Principal Investigator: You Shang, MD          Sub-Investigator: Rui Wang, MD          Sub-Investigator: Zhouxiong Xing, MD          Sub-Investigator: Yuan Yu, MD          Sub-Investigator: Shiying Yuan, MD          Sub-Investigator: Xiaojing Zhou, MD          Sub-Investigator: Hong Liu, MD          Sub-Investigator: Yuanfa Tao          Sub-Investigator: Huaqing Shu          Sub-Investigator: Yaxing Wang          Sub-Investigator: Yin Yuan          Sub-Investigator: Jiancheng Zhang          China, Jiangsu the First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Xiangrong Zuo, MD       13913979197@139.com    affiliated hospital, Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Dadong Liu, MD       583837931@qq.com    China, Shandong Binzhou People's hospital of Shandong province Recruiting Binzhou, Shandong, China Contact: Xin'an Wang, MD       wangxinan008@163.com    Sub-Investigator: Rui Yin, MD          China, Shanghai department of critical care medicine, Ren Ji Hospital, School of medicine, Shanghai Jiao Tong University Recruiting Shanghai, Shanghai, China, 200001 Contact: Yuetian Yu, MD       fishyyt@hotmail.com    China, Shanxi Peace hospital of Changzhi medical college Recruiting Changzhi, Shanxi, China Contact: Zhenhua Zhu, MD       249263735@qq.com    China, Zhejiang Zhejiang Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Caibao Hu, MD       zjicu1996@163.com    Sir Run Run Shaw hospital Recruiting Hangzhou, Zhejiang, China, 321000 Contact: jiancang Zhou, MD       jiancangzhou@hotmail.com    Sir Run Run Shaw hospital Recruiting Hangzhou, Zhejiang, China Contact: Hong Yucai          Jinhua Municipal Central Hospital Recruiting Jinhua, Zhejiang, China, 321000 Contact: zhongheng zhang    8657982553393    zh_zhang1984@hotmail.com    Contact: Xuqing Ji, MSc       xuqing_ji@163.com    Principal Investigator: kun chen, MSc          Sub-Investigator: Xiao Xu, MSc          Sub-Investigator: Hongying Ni, MMed          Principal Investigator: Zhongheng Zhang, MMed          Sub-Investigator: Xuqing Ji, MSc          Department of critical care medicine, The central hospital of Lishui City Recruiting Lishui, Zhejiang, China, 323000 Contact: Xin Tian, MD       xqjytx@163.com    Beilun People's hospital; The first affiliated hospital of Zhejiang university (Beilun Branch) Recruiting Ningbo, Zhejiang, China Contact: Zhiping Huang, MD       hnhzhp@sina.com    Taizhou hospital of Zhejiang province Recruiting Taizhou, Zhejiang, China, 317000 Contact: Chao Zhang, MD       zzcc200@163.com    The first People's hospital of Yongkang Recruiting Yongkang, Zhejiang, China Contact: Bo Ren, MD       ykrenbo@163.com Collapse <<

• 参考文献

• [1] Xing K, Fu X,. Cardioprotective Effect of Anisodamine Against Myocardial Ischemia Injury and its Influence on Cardiomyocytes Apoptosis. Cell Biochem Biophys. 2015 Dec;73(3):707-16.

  [2] Eisenkraft A, Falk A. Possible role for anisodamine in organophosphate poisoning. Br J Pharmacol. 2016 Jun;173(11):1719-27.